Glen Eagle Advisors, LLC Biolife Solutions Inc Transaction History

Glen Eagle Advisors, LLC

  • $593 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2024
SELL
$29.51 - $44.62 $885 - $1,338
-30 Closed
0 $0
Q1 2021

Aug 13, 2024
SELL
$32.95 - $44.24 $1,977 - $2,654
-60 Reduced 66.67%
30 $1.08 Million
Q4 2020

Aug 13, 2024
BUY
$27.5 - $45.75 $2,475 - $4,117
90 New
90 $3.59 Million

Others Institutions Holding BLFS

# of Institutions
199
Shares Held
45M
Call Options Held
8.2K
Put Options Held
4K
View Full List

About BIOLIFE SOLUTIONS INC

BLFS Quotes by TradingView
  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.12B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email